Heron Therapeutics Inc (USD)
HRTX
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range25.21 | 25.91
52-Wk Range15.68 | 28.70
Last Close25.42
Mkt Cap (m)2,289.11
Dividend yield-
ISINUS4277461020
Volume981,444
Exchange VenueNAS

Company Profile

Heron Therapeutics Inc is a biotechnology company, developing products to address unmet medical needs. It is developing novel, patient-focused solutions that apply its science and technologies to already-approved pharmacological agents.

Key Information
Price/Earning-
Price/Book8.02
Price/Sales14.37
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -237.42
Net Margin %-230.84
Return on Equity-71.35
Debt/Equity0.01

Legal Documents

Prospectus
en 07/10/2019
Annual Report
en 31/12/2018

Financials

Income Statement
USD201320142015201620172018
Revenue (m)13177
Operating Income (m)-54-75-97-171-195-184
Net Income (m)-55-76-98-173-197-179
Basic EPS-3.42-2.87-2.95-4.56-3.65-2.44
Avg. Diluted Shares Outstanding (m)162733385473
Balance Sheet
USD201320142015201620172018
Current Assets (m)737413562228447
Non Current Assets (m)3335615
Total Assets (m)767713867234462
Current Liabilities (m)714203910392
Total Liabilities (m)------
Total Equity (m)6963118-21131370
Cash Flows
USD201320142015201620172018
Operating Cash Flows (m)-41-60-79-134-170-192
Capital Expenditure (m)-2-1-1-3-3-9
Figures are quoted in USD unless stated otherwise
0.00 (0.00%)
$
25.42
Last Price